Enveric Biosciences, Inc. (ENVB)
Nasdaq: ENVB · Pharmaceutical Preparations · Cambridge, MA · filing with the SEC since 1996
Who owns Enveric Biosciences, Inc.
As filed with the SECHolders of 5% or more
1
Armistice Capital, LLC holds 9.99% of Common stock, par value $0.01 per share, as its SCHEDULE 13G filed Aug 14, 2026 says.
Directors and officers
8
report now, of 36 people on the record since 2013. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Armistice Capital, LLC
SCHEDULE 13G · filed Aug 14, 2026 · Common stock, par value $0.01 per share
Mitchell P. Kopin
SCHEDULE 13G · filed Feb 2, 2026 · Common Stock, par value $0.01 per share · reported falling below 5%, from 4.99% in Dec 17, 2025
Orca Capital AG
SCHEDULE 13G/A · filed Feb 4, 2025 · Common Stock, par value $0.01 per share · reported falling below 5%, from 8.7% in Feb 4, 2025
Ayrton Capital LLC
SCHEDULE 13G/A · filed Aug 13, 2026 · Common Stock, $0.01 par value per share · reported falling below 5%, from 9.99% in Nov 13, 2025
AdvisorShares Trust
SCHEDULE 13G/A · filed Jan 5, 2026 · Common Stock, $0.01 par value · reported falling below 5%, from 6.27% in Oct 3, 2025
Easton Jeff
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.01 par value · reported falling below 5%, from 7.87% in May 15, 2026
Braeden Lichti
SCHEDULE 13G/A · filed Dec 10, 2025 · Common Stock, $0.01 par value per share · reported falling below 5%, from 5.01% in Dec 5, 2025
Northstrive Fund II LP
SCHEDULE 13G/A · filed Dec 10, 2025 · Common Stock, $0.01 par value per share · reported falling below 5%, from 5.01% in Dec 5, 2025
What ENVB reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Canaccord Genuity LLC
An entity · legal entity · owns, named in the 10-K filed Mar 27, 2026
Myco Medica Life Sciences
An entity · legal entity · owns, named in the 10-K filed Mar 27, 2026
7 subsidiaries in 2 countries, from the list filed with the 10-K filed Mar 27, 2026.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2023 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.